> Details

Ackerson, Timothy; Amberg, Alexander; Atzrodt, Jens; Arabeyre, Catherine; Defossa, Elisabeth; Dorau, Martina; Dudda, Angela; Dwyer, Jacquelyn; Holla, Wolfgang; Kissner, Thomas; Kohlmann, Markus; Kürzel, Ulrich; Pánczél, József; Rajanna, Shibani; Riedel, Jens; Schmidt, Friedemann; Wäse, Kerstin; Weitz, Dietmar; Derdau, Volker

Mechanistic investigations of the liver toxicity of the free fatty acid receptor 1 agonist fasiglifam (TAK875) and its primary metabolites

Reference
management

Bookmarks

Remove from
bookmarks

Share this on Whatsapp

Close

Bookmarks



You can manage bookmarks using lists, please log in to your user account for this.
  • Media type: E-Article
  • Title: Mechanistic investigations of the liver toxicity of the free fatty acid receptor 1 agonist fasiglifam (TAK875) and its primary metabolites
  • Contributor: Ackerson, Timothy; Amberg, Alexander; Atzrodt, Jens; Arabeyre, Catherine; Defossa, Elisabeth; Dorau, Martina; Dudda, Angela; Dwyer, Jacquelyn; Holla, Wolfgang; Kissner, Thomas; Kohlmann, Markus; Kürzel, Ulrich; Pánczél, József; Rajanna, Shibani; Riedel, Jens; Schmidt, Friedemann; Wäse, Kerstin; Weitz, Dietmar; Derdau, Volker
  • Published: Wiley, 2019
  • Published in: Journal of Biochemical and Molecular Toxicology, 33 (2019) 8
  • Language: English
  • DOI: 10.1002/jbt.22345
  • ISSN: 1095-6670; 1099-0461
  • Origination:
  • Footnote:
  • Description: AbstractFor fasiglifam (TAK875) and its metabolites the substance‐specific mechanisms of liver toxicity were studied. Metabolism studies were run to identify a putatively reactive acyl glucuronide metabolite. In vitro cytotoxicity and caspase 3/7 activation were assessed in primary human and dog hepatocytes in 2D and 3D cell culture. Involvement of glutathione (GSH) detoxication system in mediating cytotoxicity was determined by assessing potentiation of cytotoxicity in a GSH depleted in vitro system. In addition, potential mitochondrial liabilities of the compounds were assessed in a whole‐cell mitochondrial functional assay. Fasiglifam showed moderate cytotoxicity in human primary hepatocytes in the classical 2D cytotoxicity assays and also in the complex 3D human liver microtissue (hLiMT) after short‐term treatment (24 hours or 48 hours) with TC50 values of 56 to 68 µM (adenosine triphosphate endpoint). The long‐term treatment for 14 days in the hLiMT resulted in a slight TC50 shift over time of 2.7/3.6 fold lower vs 24‐hour treatment indicating possibly a higher risk for cytotoxicity during long‐term treatment. Cellular GSH depletion and impairment of mitochondrial function by TAK875 and its metabolites evaluated by Seahorse assay could not be found being involved in DILI reported for TAK875. The acyl glucuronide metabolites of TAK875 have been finally identified to be the dominant reason for liver toxicity.